Nephrotoxicity of cefepime: A new cephalosporin antibiotic in rats

Journal of Pharmacology and Pharmacotherapeutics

Volumn 5, Issue 1, 2014, Pages 33-38

  Elsayed, Mossad Gamaleddin Ahmed ^a   Elkomy, Ashraf Abdelhakim Ahmed ^a   Gaballah, Mahmoud Salem ^b   Elbadawy, Mohamed ^a  

^a Benha University   (Egypt)

^b Benha University   (Egypt)

Author keywords

Biochemicals; cefepime; histopathology; nephrotoxicity; rats

Indexed keywords

CALCIUM; CEFEPIME; CREATININE; GLUCOSE; POTASSIUM; PROTEIN; SODIUM; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG CLEARANCE; GLOMERULUS; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; GLUCOSURIA; HISTOPATHOLOGY; KIDNEY TUBULE; MALE; NEPHROTOXICITY; NONHUMAN; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; UREA BLOOD LEVEL; UREA URINE LEVEL; URINE LEVEL;

EID: 84892723733     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.124419     Document Type: Article

References (30)

1. Kamiya A, Okumura K, Hori R. Quantitative investigation on renal handling of drugs in rabbits, dogs, and humans. J Pharm Sci 1983;72:440-3.
2. Tune BM. Nephrotoxicity of beta-lactam antibiotics: Mechanisms and strategies for prevention. Pediatr Nephrol 1997;11:768-72.
3. Servais H, Mingeot-Leclercq M, Tulkins BM. Antibiotics induced nephrotoxicity. In: Tarlof JB, Lash HL, editors. Target Organ Toxocology Series, Toxicology of the Kidney. 3rd ed. USA: CRC Press; 2005. p. 654-62.
4. Kuo CH, Hook JB. Depletion of renal glutathione content and nephrotoxicity of cephaloridine in rabbits, rats, and mice. Toxicol Appl Pharmacol 1982;63:292-302.
5. Goldstein RS, Pasino DA, Hook JB. Cephaloridine nephrotoxicity in aging male Fischer-344 rats. Toxicology 1986;38:43-5.
6. Goldstein RS, Smith PF, Tarloff JB, Contardi L, Rush GF, Hook JB. Biochemical mechanisms of cephaloridine nephrotoxicity. Life Sci 1988;42:1809-16.
7. Zhanel GG. Cephalosporin-induced nephrotoxicity: Does it exist? DICP 1990;24:262-5.
8. Lash LH, Tokarz JJ, Woods EB. Renal cell type specificity of cephalosporin-induced cytotoxicity in suspensions of isolated proximal tubular and distal tubular cells. Toxicology 1994;94:97-118.
9. Huang SS, Lee SC, Lee N, See LC, Tsai MH, Shieh WB. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections. J Microbiol Immunol Infect 2007;40:134-40.
10. Zobell JT, Young DC, Waters CD, Ampofo K, Cash J, Marshall BC, et al. A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatr Pulmonol 2011;46:987-90.
11. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug Information Handbook: A Comprehensive Resource for All Clinicians and Healthcare Professionals. 21st ed. Hudson, Ohio: Lexi-Comp Inc.; 2012. p. 306.
12. Sanders CC. Cefepime: The next generation? Clin Infect Dis 1993;17:369-79.
13. Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: A systematic review and meta-analysis. Lancet Infect Dis 2007;7:338-48.
14. Crossmon G. Modification of Mallory's connective tissue stain with a discussion of the principles involved. Anat Rec 1937;69:33-83.
15. Carleton HM. In: Carleton HM, Drury RA, Wallington EA, editors. Carleton's Histopathological Technique. 5th ed. New York: Oxford University Press; 1980. p. 33-48.
16. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames Iowa: Iowa State University Press; 1980. p. 39-63.
17. Honda F, Ono T, Itoh N, Mori J, Ohtsuka M, Kamitani T. General pharmacology of ceftizoxime sodium. Arzneimittelforschung 1980;30:1680-7.
18. el-Sayed MG, Hassanin MR, Hafez MH, el-Komy AA, Mohamed A. Some pharmacodynamic and biochemical aspects of cefamandole. Dtsch Tierarztl Wochenschr 1997;104:481-7.
19. Hasegawa Y, Muto N, Morita M. General pharmacology of cefadroxil (author's transl). Jpn J Antibiot 1979;32:1356-71.
20. Goto A, Amano M, Sakai A, Hara M, Takahashi N. General pharmacology of BMY-28100. Jpn J Antibiot 1990;43:1289-309.
21. Hirai S, Kodama T, Hiraiwa T, Abe N, Arai H, Ono S, et al. General pharmacology of T-2588, a new oral cephem antibiotic. Jpn J Antibiot 1986;39:958-78.
22. Morioka H, Yajima R, Inazu M, Kobayashi T, Sakaguchi T. Effect of cefodizime sodium on the kidney function in male rabbits - Single and 7-day repeated intravenous administration. J Toxicol Sci 1988;13 Suppl 1:329-60.
23. Deki T, Matsuoka A, Marutani K, Nakagawa T, Masuda K, Matsuzawa T, et al. Nephrotoxicity of cefpirome sulfate in rabbits - Single and multiple intravenous administration. J Toxicol Sci 1990;15 Suppl 3:173-200.
24. Rush GF, Heim RA, Ponsler GD, Engelhardt J. Cephaloridine-induced renal pathological and biochemical changes in female rabbits and isolated proximal tubules in suspension. Toxicol Pathol 1992;20:155-68.
25. Kato I, Ogawa M, Ueno M, Nishimura K, Sato K, Kii Y, et al. Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (8) - Nephrotoxicity study in rabbits by single oral administration. J Toxicol Sci 2001;26 Suppl 1:149-56.
26. Bristol-Myers Squibb Company. Maxipime prescribing information. Princeton, NJ: Bristol-Myers Squibb Company; 2003.
27. Zanetti G, Bally F, Greub G, Garbino J, Kinge T, Lew D, et al. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: A multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother 2003;47:3442-7.
28. Kurebe M, Yokota M, Yuda Y, Sasaki H, Niizato T, Watanabe H, et al. Toxicological studies of a new cephamycin, MT-141. II. Its subacute toxicity in rats. Jpn J Antibiot 1984;37:855-89.
29. Tune BM, Fravert D. Cephalosporin nephrotoxicity. Transport, cytotoxicity and mitochondrial toxicity of cephaloglycin. J Pharmacol Exp Ther 1980;215:186-90.
30. Wold JS, Welles JS, Owen NV, Gibson WR, Morton DM. Toxicologic evaluation of cefamandole nafate in laboratory animals. J Infect Dis 1978;137 Suppl May: S51-9.